People carrying a genetic variant of the gene coding for Mucin 5B — a component of lung mucus and needed…
Articles by Yedida Y Bogachkov PhD
Treatment with Ofev (nintedanib) was found to prevent the progression of both cancer and idiopathic pulmonary fibrosis (IPF)…
Anti-fibrotic medications, such as Esbriet (pirfenidone) and Ofev (nintedanib), are not cost-effective treatments for idiopathic pulmonary fibrosis…
If left untreated by anti-fibrotic medications, idiopathic pulmonary fibrosis (IPF) has a 50% mortality rate after three years, according…
A $5 million gift to the University of South Florida (USF) from the philanthropist and entrepreneur Timothy Ubben will be…
AstraZeneca has added a novel target for idiopathic pulmonary fibrosis (IPF) to its portfolio, which was uncovered using…
AdAlta announced that AD-214, its candidate treatment for idiopathic pulmonary fibrosis (IPF), has been successfully made into an aerosol…
The Microbiome Therapeutics Innovation Group (MTIG), a coalition of companies working to develop U.S. Food and Drug Administration (FDA)-microbiome-based…
Note: This story was updated Oct. 22, 2021, to correct information about the study that was wrongly identified as…